Background illustration for clinical trials search

Kidney Disease Clinical Trials

Browse 1,098 Kidney Disease clinical trials enrolling across the United States and Canada. 72 people applied to Kidney Disease studies last month. Search by city or state to find one near you.

Filter
1

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

for
Adrenocortical Carcinoma (ACC),
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06487481

Phase1, Recruiting

A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

for
Immunoglobulin A Nephropathy
Location: Boston MA
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06952426

Recruiting

Improving Visual Field Deficits With Noninvasive Brain Stimulation

for
Visual Field Defect, Peripheral, Stroke, Visual Impairment,
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05085210

Recruiting

Personalized NK Cell Therapy in CBT

for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 15 - 70+

Code: NCT02727803

Phase2, Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Boston MA, New York NY, Charlottesville VA,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 18 - 66

Code: NCT06859424

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)

for
Philadelphia Chromosome Negative,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18 - 50

Code: NCT06785324

Recruiting

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma Refractory/ Relapsed,
Location: New York NY, Buffalo NY, Nashville TN, St Louis MO,
Sponsor: LTZ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07121946

Phase1, Recruiting

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07040982

Phase1, Recruiting

CAR T-cell Long-Term Follow-Up, Quality of Life and Adverse Reactions

for
B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT07048535

Recruiting

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

for
Relapsed/Refractory Hematological Malignancies,
Location: East Brunswick NJ, Grand Rapids MI, Los Angeles CA
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT07424833

Phase1, Recruiting

Two Step Haplo With Radiation Conditioning

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Philadephia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT05031897

Phase2, Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Toronto, Franklin TN, Chicago IL, Iowa City IA,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07109219

Phase1, Phase2, Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Boston MA, Riverhead NY, Hartford CT, Holyoke MA,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase2, Recruiting

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07224100

Phase2, Recruiting

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

for
B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia,
Location: Little Rock AR, Springdale AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 1 - 23

Code: NCT07422337

Recruiting

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

for
Acute Lymphoblastic Leukemia, B-All
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3 - 65

Code: NCT07328503

Phase2, Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

for
Chronic Lymphocytic Leukemia, CLL, Mantle Cell Lymphoma, MCL
Location: Boston MA, Tampa FL, Fort Wayne IN, St Louis MO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06697184

Phase1, Phase2, Recruiting

What are clinical trials for kidney disease?

Clinical trials for kidney disease are research studies designed to test new treatments, interventions, or diagnostic methods aimed at improving the management and outcomes of kidney conditions including kidney disease. These trials may involve experimental medications, innovative therapies, surgical techniques, or lifestyle interventions.

The importance of kidney disease clinical trials

Kidney disease clinical trials are crucial because they help advance our understanding of kidney disorders so that more effective treatments can be developed. These trials test new drugs, therapies, and diagnostic methods, aiming to improve patient outcomes, slow disease progression, and enhance quality of life.

Clinical trials for kidney disease also provide valuable data on the safety and efficacy of new interventions, which can lead to better management strategies and potential cures. Without clinical trials, the development of innovative solutions and improvements in care for kidney disease would be limited, potentially leaving patients with fewer options and suboptimal outcomes.

Types of kidney disease clinical trials

Participation in a clinical trial for kidney disease

Who can take part in a kidney disease clinical trial?

How to enroll in a clinical trial for kidney disease